Published in Magn Reson Med on June 01, 1991
New frontiers and developing applications in 19F NMR. Prog Nucl Magn Reson Spectrosc (2012) 1.02
Correlation between 5-fluorouracil metabolism and treatment response in two variants of C26 murine colon carcinoma. Br J Cancer (2003) 0.83
Inactivation of pea leaf chloroplastic and cytoplasmic glucose 6-phosphate dehydrogenases by light and dithiothreitol. Plant Physiol (1974) 2.47
Reducing alcohol consumption. Comparing three brief methods in family practice. Can Fam Physician (1997) 2.20
Brain tissue sodium is a ticking clock telling time after arterial occlusion in rat focal cerebral ischemia. Stroke (2000) 1.68
Human neoplasm pH and response to radiation therapy: P-31 MR spectroscopy studies in situ. Radiology (1989) 1.59
NMR study of in vivo RIF-1 tumors. Analysis of perchloric acid extracts and identification of 1H, 31P and 13C resonances. Biochim Biophys Acta (1984) 1.31
Structural studies of apolipoprotein A-I/phosphatidylcholine recombinants by high-field proton NMR, nondenaturing gradient gel electrophoresis, and electron microscopy. Biochemistry (1984) 1.27
1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla. Neurology (1999) 1.20
Characterization and construction of molecular cloning vehicles within Staphylococcus aureus. J Bacteriol (1978) 1.08
Therapeutic response of breast carcinoma monitored by 31P MRS in situ. Magn Reson Med (1989) 1.06
Minimal size phosphatidylcholine vesicles: effects of radius of curvature on head group packing and conformation. Biochemistry (1982) 1.01
Brain activation during human finger extension and flexion movements. Brain Res (2000) 0.97
In vivo 31P NMR study of the metabolism of murine mammary 16/C adenocarcinoma and its response to chemotherapy, x-radiation, and hyperthermia. Proc Natl Acad Sci U S A (1983) 0.97
Application of in vivo NMR spectroscopy to cancer. Magn Reson Med (1984) 0.96
Screening for hazardous drinking. Using the CAGE and measures of alcohol consumption in family practice. Can Fam Physician (1994) 0.92
Loss of high-energy phosphate following hyperthermia demonstrated by in vivo 31P-nuclear magnetic resonance spectroscopy. Cancer Res (1984) 0.90
Immunomagnetic isolation of magnetoferritin-labeled cells in a modified ferrograph. Cytometry (1996) 0.89
Postictal alteration of sodium content and apparent diffusion coefficient in epileptic rat brain induced by kainic acid. Epilepsia (1996) 0.89
Effect of the delta subunit on assembly and proton permeability of the F0 proton channel of Escherichia coli F1F0 ATPase. J Bacteriol (1991) 0.85
19F magnetic resonance spectroscopy studies of the metabolism of 5-fluorouracil in murine RIF-1 tumors and liver. Cancer Res (1991) 0.84
Direct relationship between high-energy phosphate content and blood flow in thermally treated murine tumors. J Natl Cancer Inst (1985) 0.84
Temporal changes in proton MRS metabolites after kainic acid-induced seizures in rat brain. Epilepsia (1997) 0.84
MRS metabolic markers of seizures and seizure-induced neuronal damage. Epilepsia (1998) 0.83
Oxygenation and metabolic status of KHT tumors as measured simultaneously by 19F magnetic resonance imaging and 31P magnetic resonance spectroscopy. Magn Reson Imaging (1996) 0.83
Magnetic resonance imaging of cutaneous melanocytic lesions. J Dermatol Surg Oncol (1989) 0.83
Human tumors as examined by in vivo 31P NMR in athymic mice. Biochem Biophys Res Commun (1982) 0.82
Neuronal pathology in the wobbler mouse brain revealed by in vivo proton magnetic resonance spectroscopy and immunocytochemistry. Neuroreport (1998) 0.81
Shielded solenoidal probe for in vivo NMR studies of solid tumors. Magn Reson Med (1985) 0.80
Phosphorus-31 nuclear magnetic resonance analysis of epidermal growth factor action in A-431 human epidermoid carcinoma cells and SV-40 virus transformed mouse fibroblasts. Biochemistry (1983) 0.79
Presence of a progesterone-induced, uterine specific, acid phosphatase in allantoic fluid of gilts. J Anim Sci (1975) 0.78
Detection of antineoplastic agent induced cardiotoxicity by 31P NMR of perfused rat hearts. Biochem Biophys Res Commun (1983) 0.78
Effect of adenosine deaminase inhibitors on the heart's functional and biochemical recovery from ischemia: a study utilizing the isolated rat heart adapted to 31P nuclear magnetic resonance. J Cardiovasc Pharmacol (1984) 0.77
Short echo time proton spectroscopy of human brain using a gradient head coil. Magn Reson Imaging (1992) 0.77
Response of a non-Hodgkin lymphoma to 60Co therapy monitored by 31P MRS in situ. Int J Radiat Oncol Biol Phys (1987) 0.77
Growth and magnetic resonance characteristics of human squamous cell carcinoma xenografts implanted with cells suspended in Matrigel. NMR Biomed (1994) 0.77
Thymidine-modulated 5-fluorouracil metabolism in liver and RIF-1 tumors studied by 19F magnetic resonance spectroscopy. Magn Reson Imaging (1992) 0.77
Depth pulse sequences for surface coils: spatial localization and T1 measurements. Magn Reson Med (1984) 0.77
Magnetic resonance imaging of cutaneous neoplasms: clinicopathologic correlation. J Dermatol Surg Oncol (1991) 0.76
Beagle 2: a proposed exobiology lander for ESA's 2003 Mars Express mission. Adv Space Res (1999) 0.76
In situ 19F MRS measurement of RIF-1 tumor blood volume: corroboration by radioisotope-labeled [125I]-albumin and correlation to tumor size. Magn Reson Imaging (1996) 0.75
Less well known parameters of in vitro radiosensitivity. J Natl Med Assoc (1989) 0.75
Preliminary clinical experience with pretransplant assessment of renal viability by phosphorus-31 magnetic resonance spectroscopy (31P-MRS). Transplant Proc (1988) 0.75
Induction of apoptosis within T lymphoblastoid cells by a topoisomerase I inhibitor. Biochem Soc Trans (1997) 0.75
Phosphorus metabolites and the distribution of cell cycle phase of RIF-1 tumors in response to 14 Gy irradiation. Magn Reson Med (1990) 0.75
Monitoring therapeutic response of human superficial tumors using phase-encoded spectroscopy. Magn Reson Med (1989) 0.75
Spectral editing of tumor 13C MRS in situ. Magn Reson Med (1990) 0.75
In vivo renal viability assessment by 31P magnetic resonance spectroscopy in an exteriorized kidney. Transplant model. Contrib Nephrol (1987) 0.75
31P magnetic resonance spectroscopy detection of response-predictive adenosine triphosphate decrease in irradiated radiation-induced fibrosarcoma-1 tumors. Invest Radiol (1997) 0.75
In vivo measurement of 31P nuclear magnetic resonance spectrum of aging mouse brain. Physiol Chem Phys Med NMR (1983) 0.75
Oblique proton chemical shift imaging for the presurgical localization of mesial temporal epilepsy. Magn Reson Med (1997) 0.75
Gd-DISIDA--a potential contrast agent for magnetic resonance imaging of the hepatobiliary system. J Nucl Med Allied Sci (1989) 0.75
Mean inactivation dose (D). A critical analysis of a neglected parameter in radiotherapy. Acta Oncol (1990) 0.75
Preliminary observations on the correlation of proliferative phenomena with in vivo 31P NMR spectroscopy after tumor chemotherapy. Ann N Y Acad Sci (1985) 0.75
Postictal in situ MRS brain lactate in the rat kindling model. Neurology (1999) 0.75
Clinical experience with pretransplant assessment of renal viability by phosphorus-31 magnetic resonance spectroscopy (31P-MRS) in 40 recipient patients. Transplant Proc (1989) 0.75
In vivo MR spectroscopy of human subjects with a 1.4-T whole-body MR imager. Radiology (1986) 0.75
The archive of the Society for the Protection of Science and Learning. Hist Sci (1989) 0.75
Human in vivo 31P spectroscopy of skin: potentially a powerful tool for noninvasive study of metabolism in a cutaneous tissue. J Dermatol Surg Oncol (1989) 0.75